These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 853545)

  • 1. Relay residue studies: a modification of the relay toxicity approach.
    Craine EM
    J Toxicol Environ Health; 1977 Mar; 2(4):905-7. PubMed ID: 853545
    [No Abstract]   [Full Text] [Related]  

  • 2. 1984 Stokinger lecture. Some questions and opinions on issues in toxicology and risk assessment.
    Weil CS
    Am Ind Hyg Assoc J; 1984 Oct; 45(10):663-70. PubMed ID: 6496314
    [No Abstract]   [Full Text] [Related]  

  • 3. The toxicological evaluation of drug residues.
    Morton DM
    J Environ Pathol Toxicol; 1980; 3(5-6):65-72. PubMed ID: 7441101
    [No Abstract]   [Full Text] [Related]  

  • 4. Food and drug administration statement of problem.
    Perez MK
    J Toxicol Environ Health; 1977 Mar; 2(4):727-30. PubMed ID: 558337
    [No Abstract]   [Full Text] [Related]  

  • 5. Selection of laboratory animals for drug safety evaluation.
    Glocklin VC
    Lab Anim Care; 1969 Oct; 19(5):700-1. PubMed ID: 4247432
    [No Abstract]   [Full Text] [Related]  

  • 6. Safety assessment of drug residues.
    Jackson BA
    J Am Vet Med Assoc; 1980 May; 176(10 Spec No):1141-4. PubMed ID: 6894293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analytical methodology and the interface with animal drug approval.
    Perez MK
    J Assoc Off Anal Chem; 1978 Sep; 61(5):1183-91. PubMed ID: 581494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are single-dose toxicology studies in animals adequate to support single doses of a new drug in humans?
    Monro A; Mehta D
    Clin Pharmacol Ther; 1996 Mar; 59(3):258-64. PubMed ID: 8653987
    [No Abstract]   [Full Text] [Related]  

  • 9. Response to Monro and Mehta proposal for use of single-dose toxicology studies to support single-dose studies of new drugs in humans.
    Choudary J; Contrera JF; DeFelice A; DeGeorge JJ; Farrelly JG; Fitzgerald G; Goheer MA; Jacobs A; Jordan A; Meyers L; Osterberg R; Resnick C; Sun CJ; Temple RJ
    Clin Pharmacol Ther; 1996 Mar; 59(3):265-7. PubMed ID: 8653988
    [No Abstract]   [Full Text] [Related]  

  • 10. Chiral toxicology: it's the same thing...only different.
    Smith SW
    Toxicol Sci; 2009 Jul; 110(1):4-30. PubMed ID: 19414517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A regulatory perspective on issues and approaches in characterizing human metabolites.
    Davis-Bruno KL; Atrakchi A
    Chem Res Toxicol; 2006 Dec; 19(12):1561-3. PubMed ID: 17173368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety considerations in development of new animal drugs.
    Fogleman RW
    J Am Vet Med Assoc; 1972 Dec; 161(11):1381-4. PubMed ID: 4638516
    [No Abstract]   [Full Text] [Related]  

  • 13. General considerations for studies of the metabolism of drugs and other chemicals.
    Glocklin VC
    Drug Metab Rev; 1982; 13(6):929-39. PubMed ID: 6754317
    [No Abstract]   [Full Text] [Related]  

  • 14. [Toxicity caused by so-called reactive metabolites of drugs].
    Pessayre D; Mazel P; Benhamou JP
    Nouv Presse Med; 1976 May; 5(18):1201-4. PubMed ID: 775438
    [No Abstract]   [Full Text] [Related]  

  • 15. Summarization: assessment of current status of available methodologies to utilize radioactive drug metabolism studies for determining safety of animals.
    Huber WG
    J Toxicol Environ Health; 1977 Mar; 2(4):913-5. PubMed ID: 558339
    [No Abstract]   [Full Text] [Related]  

  • 16. Welcome to MIST and bioanalysis. Foreword.
    Chaudhary A
    Bioanalysis; 2010 Jul; 2(7):1169-70. PubMed ID: 21083228
    [No Abstract]   [Full Text] [Related]  

  • 17. [Introduction to toxicology: methods for the determination of toxicity of substances. II].
    Reith JF
    Pharm Weekbl; 1969 Oct; 104(44):1373-85. PubMed ID: 5352088
    [No Abstract]   [Full Text] [Related]  

  • 18. In vitro metabolic interaction studies: experience of the Food and Drug Administration.
    Yuan R; Parmelee T; Balian JD; Uppoor RS; Ajayi F; Burnett A; Lesko LJ; Marroum P
    Clin Pharmacol Ther; 1999 Jul; 66(1):9-15. PubMed ID: 10430104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer-causing substances in food, drugs, and cosmetics. The de minimis rule versus the Delaney clause.
    Curran WJ
    N Engl J Med; 1988 Nov; 319(19):1262-4. PubMed ID: 3273488
    [No Abstract]   [Full Text] [Related]  

  • 20. Overdosage and-or poisoning--the information gap.
    Ellenhorn MJ
    J Clin Pharmacol; 1973; 13(5):181-9. PubMed ID: 4488653
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.